Atlas Trials

Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Post-Herpetic Neuralgia

Clinical trial NCT00981227 · COMPLETED

Trial details

NCT number
NCT00981227
Sponsor
Bial - Portela C S.A.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Postherpetic Neuralgia
Start date
2007-11-01
Primary completion
2009-01-01
Enrollment
567

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.